ANA is one of the few centers in the region offering experimental treatment options for Alzheimer’s disease.
New treatments offer unique opportunities to treat Alzheimer’s Disease Read More »
Dr. Klein argues that physicians should be made aware if pharmacies switch a physician-prescribed product for a biosimilar.
Dr. Klein discusses biosimilars and biologics in the Philadelphia Business Journal Read More »
The Diamond Stroke Center is named after one of ANA’s founders, Dr. B. Franklin Diamond.
Abington Memorial Hospital attains elite status of Comprehensive Stroke Center Read More »
This bill ensures that patients and physicians are made aware if the pharmacist substitutes a biosimilar product.
Dr. Klein testifies in state congress on behalf of physicians and patients Read More »
Fifteen members of the American Headache Society reviewed the existing literature and developed a standard procedure for nerve blocks.
Dr. Klein co-authors panel publication in Headache Read More »
Dr. Burke is one of ANA’s longest-serving physicians.
ANA physician named “Top Doc” by Philadelphia Magazine Read More »
